CJC-1295 / Ipamorelin – 10mg / 10mg

CJC-1295 / Ipamorelin (10mg / 10mg) is a research-grade peptide formulation studied for its interaction with growth-hormone signaling and metabolic-balance pathways. CJC-1295 and Ipamorelin are researched for their potential influence on pathways related to body composition, cellular repair, and metabolic efficiency, making this formulation a compound of interest for studies focused on physical performance, metabolic optimization, and cellular health. For additional information, click here. This formulation is intended for research use only, and its applications outside of laboratory settings have not been established.

CJC-1295 / Ipamorelin (10mg/10mg) is a research-grade peptide formulation, supplied by Advanced Peptide Institute for laboratory research use only. It is studied in laboratory research for its interaction with growth-hormone-releasing and secretagogue receptor pathways. Advanced Peptide Institute supplies CJC-1295 / Ipamorelin in this 10mg/10mg format at 99% purity, third-party tested.

What is CJC-1295 / Ipamorelin?

CJC-1295 / Ipamorelin combines two research peptides from the growth-hormone-releasing pathway family, offered here in a 10mg/10mg dosage format. CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH), a naturally occurring hypothalamic peptide, and belongs structurally to the class of long-acting GHRH analogs used in laboratory research. Ipamorelin is a synthetic pentapeptide belonging to the growth hormone secretagogue class, studied for its interaction with secretagogue receptor pathways distinct from the GHRH receptor pathway. In laboratory research, these two peptides are frequently paired because CJC-1295 is studied in connection with growth-hormone-releasing receptor pathways, while Ipamorelin is studied in connection with a related but distinct secretagogue receptor pathway, allowing researchers to examine both pathway families within a single research model at a matched 1:1 ratio.

Research Applications

Researchers studying growth-hormone-releasing signaling commonly examine CJC-1295 in laboratory research models involving hypothalamic-pituitary pathway research. Ipamorelin is studied in research contexts involving secretagogue receptor pathways, often using in vitro receptor-binding assays and in vivo research models. The 10mg/10mg format is intended for researchers who require this specific concentration ratio for their laboratory protocols investigating both pathway families together, providing an equal-mass reference point for comparative study designs across growth-hormone-releasing and secretagogue receptor pathway research. All research applications described here refer strictly to laboratory and in vitro/in vivo model research, not to any use in humans or animals outside a controlled research setting.

Purity & Third-Party Testing

Advanced Peptide Institute CJC-1295 / Ipamorelin is supplied at 99% purity, verified by independent third-party HPLC testing and mass spectrometry. Each incoming batch is tested for identity and purity before it is released, and the resulting Certificate of Analysis lists the analytical methods and results used to confirm the compound matches its labeled specification. The COA for every batch is available at advancedpeptideinstitute.com/certificate-of-analysis, so researchers can review purity data before including the compound in a laboratory protocol.

Storage & Handling

Store lyophilised CJC-1295 / Ipamorelin at −20°C for long-term stability, protected from light and moisture. Refrigerate at 2–8°C after reconstitution and use within 4–6 weeks for research consistency. Avoid repeated freeze-thaw cycles once reconstituted, and keep the vial sealed between uses to help preserve compound integrity for both peptides in the formulation.

Frequently Asked Questions

What purity is Advanced Peptide Institute CJC-1295 / Ipamorelin?

Advanced Peptide Institute CJC-1295 / Ipamorelin is supplied at 99% purity, verified by independent third-party HPLC testing and mass spectrometry. A Certificate of Analysis is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/.

How should CJC-1295 / Ipamorelin be stored?

Store lyophilised compound at −20°C for long-term stability. Refrigerate at 2–8°C after reconstitution and use within 4–6 weeks.

Is CJC-1295 / Ipamorelin intended for human use?

No. CJC-1295 / Ipamorelin is supplied strictly for laboratory research use only and is not intended for human or animal consumption. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Only qualified researchers working in a controlled laboratory setting should handle this compound, in accordance with standard research-chemical handling practices.

Published laboratory research on CJC-1295 and ipamorelin is indexed on PubMed.

Related Research Compounds: NAD+ -1000mg • BPC Wolverine + KPV – 10mg / 10mg / 10mg • Browse all Best Sellers research compounds • Certificate of Analysis • GH secretagogue research

For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.